USPTO serial 79155972
DBV TECHNOLOGIES
Reviewed by CopyMark Law Group
Reg. 4834100Status 404
- Filing date
- Status date
- Registration date
- Oct 20, 2015
- Examiner
- CASE, LEIGH CAROLINE
- Law office
- PETITIONS OFFICE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DBV TECHNOLOGIES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicated adhesive devices in the nature of epicutaneous patches for enabling cutaneous or epicutaneous administration of medicated or pharmaceutical substances in powder form for humans and animals for the treatment of allergies, inflammatory and autoimmune diseases; epicutaneous patches featuring a preparation in powder form for medical purposes for the treatment of allergies, inflammatory and autoimmune diseases; medicated occlusion patches in the nature of epicutaneous patches for enabling the absorption of a medicated substance in powder form via the skin for the treatment of allergies, inflammatory and autoimmune diseases | SECTION 71 - CANCELLED | — |
| 010 | Medical apparatus, instruments and devices, namely, epicutaneous patches sold without medication for the cutaneous or epicutaneous administration of substances of medicated or cosmetic substances in powder form for humans or animals; occlusion patch dispensers for medical purposes; medical instruments using the electrostatic properties of a biocompatible support, namely, epicutaneous patches sold without medication | SECTION 71 - CANCELLED | — |
| 042 | Medical and scientific research in the field of immunotherapy, namely, designing scientific methods for epicutaneous immunotherapy, inflammatory and autoimmune diseases without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact; scientific research in the field of treating and caring for allergies; scientific research in the field of allergy treatment for a treatment to be applied repeatedly to the skin of the patient without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact and thus avoiding the passage of the allergen into the blood; drug discovery services for the discovery of allergen drugs; medical and scientific research, namely, designing methods for treating allergies via the combination of allergens with immune cells in the skin; medical and scientific research, namely, designing methods for treating allergies, inflammatory and autoimmune diseases via the application of a patch to the unbroken skin of the patient without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact | SECTION 71 - CANCELLED | — |
| 044 | Medical services that use a desensitization method that uses immunotherapy; medical treatments of allergies, inflammatory and autoimmune diseases via administration of allergens, antigens using a patch to be affixed to the unbroken skin of the patient, thus avoiding the allergen being transferred into the blood; medical treatments of allergies, inflammatory and autoimmune diseases that use the epicutaneous method of desensitization via immunotherapy; epicutaneous medical treatments of allergies, inflammatory and autoimmune diseases without prior preparation of the skin other than for simple, light cleansing to keep the cellular structure of the epidermis intact; medical consultancy in the field of desensitization to allergies relating to desensitization to combat allergies | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DBV TECHNOLOGIES (Société Anonyme)
- Other trademarks owned by DBV TECHNOLOGIES
- Other trademarks owned by DBV TECHNOLOGIES (Société Anonyme)
- Other trademarks owned by DBV TECHNOLOGIES (Société Anonyme)
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named DBV TECHNOLOGIES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 8, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jul 13, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jun 15, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 20, 2023 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 24, 2023 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Feb 24, 2023 | INPC | INVALIDATION PROCESSED | — |
| Jan 6, 2023 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 6, 2022 | C71T | CANCELLED SECTION 71 | — |
| Nov 1, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 4, 2017 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Apr 15, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 29, 2016 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Feb 29, 2016 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jan 20, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 20, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 16, 2015 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Sep 16, 2015 | APET | ASSIGNED TO PETITION STAFF | — |
| Sep 10, 2015 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Aug 4, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 15, 2015 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 27, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 27, 2015 | ALIE | ASSIGNED TO LIE | — |
| Jun 10, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 1, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 1, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 1, 2015 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 21, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 29, 2015 | CNCF | CONTINUATION OF FINAL REFUSAL MAILED | — |
| Apr 29, 2015 | CNCF | ACTION CONTINUING A FINAL - COMPLETED | — |
| Apr 14, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 13, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 13, 2015 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 23, 2015 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 22, 2015 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 26, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 26, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 26, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 4, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 16, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 16, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 13, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 12, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 12, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 8, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 8, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 4, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |